Description
An activator of the RLR pathway; induces expression of the innate immune genes RIG-1, MDA5, IFIT1, IFIT2, IFITM1, OAS3, and Mx1 in PMA-stimulated THP-1 cells; reduces West Nile and dengue viral RNA levels in HEK293 and Huh7 cells, respectively (20 μM); inhibits HCV replication in a concentration-dependent manner in Huh7 cells
Formal name: 7-[(2-benzothiazolylamino)[4-(difluoromethoxy)phenyl]methyl]-8-quinolinol
Synonyms:
Molecular weight: 449.5
CAS: 446826-86-4
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Antivirals||Product Type|Biochemicals|Receptor Pharmacology||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Infectious Disease|Viral Diseases|Dengue||Research Area|Infectious Disease|Viral Diseases|Hepatitis||Research Area|Infectious Disease|Viral Diseases|West Nile Virus